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1. Introduction 
Long-chain aliphatic hydrocarbons, as part of the 
normal mammalian diet, are absorbed in appreciable 
amounts [l-3]. They have been found as minor 
constituents of mammalian brain [4], human arterial 
tissue and plaques [5,6], meninges and meningiomas 
[71. 
In the rat, dietary aliphatic hydrocarbons are 
absorbed mainly through the small intestine [3] and 
are oxidized to fatty acids [&lo]. Oxidation of 
saturated long-chain hydrocarbons proceeds by 
terminal hydroxylation [l l] catalyzed by micro- 
somal mono-oxygenases [12- 141, which have been 
found in mammalian intestine, liver, lung and kidney. 
We have previously shown [ 151 that myelinating 
rat brain can oxidize intracerebrally administered 
n-hexadecane to the corresponding fatty alcohol and 
fatty acid, and that both n-hexadecanol and palmitic 
acid are incorporated as such into brain phospho- 
lipids. 
We now present evidence for the biological oxida- 
tion of intracerebrally administered I-heptadecene at 
both the saturated and unsaturated ends of the 
molecule. Thus, 16-heptadecen-l-01 and 16-hepta- 
decenoic acid, as well as 1,2-heptadecanediol, are 
produced and incorporated into brain phospholipids. 
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2. Materials and methods 
Lipid standards such as long-chain alcohols, 
aldehydes, 1,2-alkanediols, l-O-2’-hydroxyalkyl 
glycerols and their derivatives were prepared as 
described previously [ 15-221. 1-Heptadecene was 
purchased from Lachat Biochemical Co., Chicago, Ill. 
and I-[ l-‘4C] heptadecene (sp. act. 18.5 mCi/mmole) 
from ICN Isotope and Nuclear Division, Irvine, Cal. 
The latter was purified by t.1.c. on Silica Gel H using 
hexane as developing solvent to a radiopurity (by 
t.1.c. and g.1.c.) of 99.5%. The substrate was emulsi- 
fied with aqueous sodium choleate (10 mg/ml) and 
injected into the brains of 18-day-old male Sprague- 
Dawley rats (Dan Rolfsmeyer Co., Madison, Wis.). 
Animals, in groups of five, were killed after 12, 24 
and 48 h, the brains of each group were pooled, and 
the lipids were extracted [23]. Methods for the 
fractionation of neutral and polar lipids by t.l.c., 
their isolation, degradation and analysis by g.1.c. were 
as described previously [ 15-2 l] . 
Periodate cleavage of 1,2-heptadecanedioi was 
carried out in pyridine [22]. Water was added and 
the reaction products were extracted with diethyl 
ether. The formaldehyde present in the aqueous 
phase was precipitated with dimedone (in 50% 
aqueous ethanol) in the presence of sodium arsenite 
and the dimedone derivative analyzed by t.1.c. using 
hexane-diethyl ether, 3:2 (v/v). 
Identifications of radioactive fractions in t.1.c. and 
g.1.c. were based on the use of synthetic internal 
standards. Radioactivities were determined with a 
Packard Tri-Carb liquid scintillation spectrometer in 
Permablend (Packard) counting solution except for 
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phospholipids for which Aquasol (New England 
Nuclear) was used. 
3. Results and discussion 
Radioactivity from intracerebrally. administered 
1-[1-14C]heptadecene (2.75 X lo6 dpm per brain) 
was found to be incorporated into the neutral and 
polar lipids of the brain. After 12, 24 and 48 h, 
approx. 20% of the administered radioactivity was 
recovered in the total lipids (5.30, 5.06 and 5.19 X 
10’ dpm per brain, respectively). Analysis of small 
aliquots by t.1.c. showed most of the radioactivity to 
be associated with unmetabolized substrate and with 
polar lipids as demonstrated in fig. 1 for the 48 h 
group. 
Small amounts of radioactivity were also present 
(fig. 1 A) in fractions corresponding to fatty alcohol 
(b) and 1,2-alkane-diol (c). They were isolated and 
identified as 16-heptadecene-l-01 and 1,2-hepta- 
decanediol by the following methods: 
Fatty alcohol: In g.l.c., using a homologous series 
of alkyl acetates as carrier, the acetylated compound 
cochromatographed with octadecyl acetate and, 
after catalytic hydrogenation, with heptadecyl acetate. 
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Fig.1. Radioactivity in t.1.c. fractions of total brain lipids 
(48 h group). Silica Gel H (Merck). (A) Hexane-ethyl 
acetate-acetic acid, 70: 30: 2 (v/v/v); Permablend scintillator. 
(B) Chloroform-methanol-water, 65:25:4 (v/v/v); Aquasol 
scintillator. Migration rates of standards: (a) fatty acid, (b) 
fatty alcohol, (c) 1,2-alkanediol, (d) ethanolamine phos- 
phatides, (e) choline phosphatides. 
Table 1 
Incorporation of radioactivity from l-[ 1-“C] heptadecene 
into rat brain lipids 
Percent of total r’C 
recovered after 
12h 24 h 48 h 
Substrate 89.8 84.2 67.8 
16-heptadecene-l-01 0.3 0.5 0.4 
1,2_heptadecanediol 1.2 1.5 2.0 
Ethanolamine phosphatides 2.8 5.4 12.2 
Choline phosphatides 5.9 8.4 17.6 
Alkanediol: In t.1.c. and, after preparation of the 
isopropylidene derivative, in g.1.c. the radioactive 
fraction cochromatographed with 1,2-heptadecane- 
diol. Periodate cleavage of the vicinal hydroxy groups 
and precipitation of the formaldehyde with dimedone 
yielded virtually all radioactivity in the dimedone 
derivative. 
The relative amounts of radioactivity present in 
various lipid fractions are listed in table 1. From the 
presence of a long-chain 1,2-alkanediol in the brain 
lipids, one would expect the formation of hydroxy- 
and oxo-substituted alkyl glycerophosphatides [17, 
211 as well as phospholipids having a 1,2alkanediol 
backbone [ 191. A long-chain o-unsaturated alcohol 
should yield w-unsaturated alkyl, alk-1-enyl and acyl 
moieties in the glycerophosphatides [16,181. Degra- 
dation of the total polar lipids (48 h) by converting 
the alk-1 -enyl moieties to 1,3dioxanes followed by 
hydrogenolysis with Vitride reagent and t.1.c. of the 
reaction products as described [20], confirmed the 
presence of these structures as demonstrated in 
fig.2. 
Analysis of the alcohols (as acetates) by g.1.c. 
showed that about 75% of the radioactivity in the 
acyl moieties had been in 16-heptadecenoic acid, the 
rest in unidentified fractions. After catalytic hydro- 
genation, about 80% of the radioactivity was eluted 
with the Cr, and 20% with the Cl9 derivative. Almost 
all radioactivity (>95%) in both alk-1-enyl glycerols 
(as dioxanes) and alkyl glycerols (as isopropylidene 
derivatives) was found to be in w-unsaturated CrT- 
derivatives. Virtually all radioactivity in the alkane- 
diol fraction was in 1,2_heptadecanediol (g.1.c. of 
isopropylidene derivative) and in the hydroxyalkyl 
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Fig.2. Radioactivity in t.1.c. fractions of products derived 
from total polar lipids (48 h group). (A) Hexane-diethyl 
ether, 1: 1 (v/v); (B) Refractionation of polar products of 
(A) after acetylation. Hexane-diethyl ether, 9: 1 (v/v), 
developed three times. Permablend scintillator. Migration 
rates of standards: (a) alkyl dioxane, (b) fatty alcohol, 
(c) alkyl glycerol, (d) 1,2-alkanediol diacetate, (e) alkyl- 
glycerol diacetate, (f) hydroxyalkyl glycerol triacetate. 
glycerol fraction in 1 -o-2’-hydroxyheptadecyl 
glycerol (GLC of the triacetate). Analysis of ethanol- 
amine and choline phospholipids individually (table 
2) confirmed these findings. 
Our results show that myelinating rat brain is 
capable of metabolizing intracerebrally administered 
I-heptadecene not only by oxidation of the methyl 
group to yield an o-unsaturated alcohol, but also by 
oxidation of the double bond to yield a 1,2alkane- 
diol, presumably through the corresponding epoxide. 
A microsomal epoxide hydratase of rat liver has 
Table 2 
Distribution (%) of radioactivity in hydrogenolysis products 
of rat brain ethanolamine (EPG) and choline (CPG) 
phosphoglyceride fractions 48 h after administration 
of l-[ 1-“Clheptadecene 
EPG CPG 
Alcohols (from total acyl groups) 
1-O-alk-l’-enyl glycerols 
l-O-alkyl glycerols 
1-O-2’-hydroxyalkyl glycerols 
1,2-alkanediols 
31.5 79.4 
45.3 - 
10.0 11.8 
7.2 5.3 
tr 3.5 
100 
been studied extensively because of its importance 
in the metabolic inactivation of the epoxides produced 
from polycyclic hydrocarbons and other potentially 
carcinogenic xenobiotics ([24,25] and references 
therein). To our knowledge, the formation of an 
alkanediol from a long-chain monounsaturated hydro- 
carbon in a mammalian system has not been reported. 
The resulting 1,2-alkanediol is not only incorporated 
into brain lipids but is efficiently degraded by oxida- 
tion and decarboxylation [ 17,2 1 ] . 
As previously demonstrated [ 181 for polyunsatu- 
rated alcohols, our present data show that an 
w-unsaturated alcohol is readily incorporated into 
ether lipids and the resulting o-unsaturated alkyl 
moiety of the alkylacyl EPG is desaturated to yield 
the corresponding plasmalogen. 
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